Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
Aditxt, Inc. (ADTX)
Company Research
Source: Business Wire
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target acquisition, Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (“Appili”). Shareholders of Appili overwhelmingly voted in favor of a plan of arrangement for Aditxt to acquire all issued and outstanding Class A common shares of Appili. For additional information and results of Appili’s special meeting of shareholders, please visit this link.About Appili TherapeuticsAppili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. Appili aims to strategically develop a pipeline of novel therapies to prevent deaths and improve lives by systematically identifying urgent infections with unmet needs. The Company is currently
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024PR Newswire
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]Canadian Business Journal
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Yahoo! Finance]Yahoo! Finance
ADTX
Sec Filings
- 11/21/24 - Form 8-K/A
- 11/21/24 - Form 8-K/A
- 11/19/24 - Form 8-K
- ADTX's page on the SEC website